Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • Searching Asian documents: patent search and monitoring services
      • EP full-text search
      • Bibliographic coverage in Espacenet and OPS
      • Full-text coverage in Espacenet and OPS
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Searching Asian documents
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Patent insight reports
    • Data
      • Overview
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge

    UP search

    Learn about the Unitary Patent in patent knowledge products and services

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact on your files
      • Online Filing & fee payment outages
      • Tutorials
    • Find a professional representative
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Unitary Patent

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • EPC Guidelines
      • PCT-EPO Guidelines
      • Guidelines revision cycle
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National law relating to the UP
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives

    legal text

    Legal texts

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • Watch the 2022 ceremony
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Firefighting technologies
      • Green tech in focus
      • CodeFest on Green Plastics
      • Clean energy technologies
      • IP and youth
      • Research institutes
      • Women inventors
      • Fighting coronavirus
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    Listen to our podcast

  • Learning

    Learning

    The e-Academy – the point of access to your learning

    Go to overview 

    • Overview
    • European Patent Academy
      • Overview
      • Learning activities
      • Learning paths
    • Professional hub
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by area by profile
      • Overview
      • Business and IP managers
      • EQE candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)

    European Patent Academy

    Boost your IP knowledge with (e-)training from the European Patent Academy

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • A glimpse of the planned activities
      • Kids’ collaborative art competition
      • 50 Leading Tech Voices
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Governance
      • Overview
      • Communiqués
      • Calendar
      • Select Committee documents
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Public consultation on the EPO's Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Social responsibility
      • Overview
      • Environment and sustainability
      • Art collection
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s

    about us

    Patent Index 2022

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
  • New to patents
    • Go back
    • Overview
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Your business and patents
    • Is it patentable?
    • Are you first?
    • Why do we have patents?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • Searching Asian documents
      • EP full-text search
      • Bibliographic coverage in Espacenet and OPS
      • Full-text coverage in Espacenet
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
            • Go back
            • Overview
            • BG - Federated Register Service
            • GB - Federated Register Service
            • NL - Federated Register Service
            • MK - Federated Register Service
            • ES - Federated Register Service
            • GR - Federated Register Service
            • SK - Federated Register Service
            • FR - Federated Register Service
            • MT - Federated Register Service
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Searching Asian documents
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Patent insight reports
    • Data
      • Go back
      • Overview
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
          • Go back
          • EBD files (weekly download) - free of charge
            • Go back
            • Secure EBD ST.36 files (weekly download) - for national patent offices only
        • Boards of Appeal decisions
        • EP full-text data for text analytics
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Helpful resources
      • Go back
      • Overview
      • First time here? Patent information explained.
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Unitary Patent Guide
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Online Filing 2.0 pilot
        • MyEPO Portfolio - pilot phase
        • Online Filing 2.0 pilot continuation
        • Exchange data with us using an API
      • Get access
        • Go back
        • Overview
        • Installation and activation
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact on your files
      • Online Filing & fee payment outages
      • Tutorials
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • EPC Guidelines
        • Go back
        • Overview
        • Archive
      • PCT-EPO Guidelines
        • Go back
        • Overview
        • Archive
      • Guidelines revision cycle
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • Watch the 2023 ceremony
      • European Inventor Network
        • Go back
        • Activities granted in 2023
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • CodeFest on Green Plastics
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • IP and youth
      • Research institutes
      • Women inventors
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Patents and standards
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • European Patent Academy
      • Go back
      • Overview
      • Learning activities
      • Learning Paths
    • Professional hub
      • Go back
      • Overview
      • EPAC - European patent administration certification
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Archive
        • Candidates successful in the European qualifying examination
        • Compendium
          • Go back
          • Overview
          • Pre-examination
          • Paper A
          • Paper B
          • Paper C
          • Paper D
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
        • Go back
        • Overview
        • Patent enforcement in Europe
        • Patent litigation in Europe
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventors' handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
            • Go back
            • Overview
            • Is the idea ‘obvious’?
            • Prior art searching
            • Professional patent searching
            • Simple Espacenet searching
            • What is prior art?
            • Why is novelty important?
          • Competition and market potential
            • Go back
            • Overview
            • Research guidelines
          • Assessing the risk ahead
            • Go back
            • Overview
            • Exploitation routes
            • Significant commercial potential
            • Significant novelty
            • What about you?
            • What if your idea is not novel but does have commercial potential?
          • Proving the invention
            • Go back
            • Overview
            • Help with design or redesign
            • Prototype strategy
          • Protecting your idea
            • Go back
            • Overview
            • Forms of IPR
            • Patenting strategy
            • The patenting process
          • Building a team and seeking funding
            • Go back
            • Overview
            • Building a team
            • Sources of funding
            • Sources of help for invention
          • Business planning
            • Go back
            • Overview
            • Constructing a business plan
            • Keep it short!
          • Finding and approaching companies
            • Go back
            • Overview
            • First contact
            • Meetings
          • Dealing with companies
            • Go back
            • Overview
            • Advance or guaranteed payment
            • Companies and your prototype
            • Full agreement – and beyond
            • Negotiating a licensing agreement
            • Reaching agreement
            • Royalties
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • For IP professionals
          • For business decision-makers
          • For stakeholders of the innovation ecosystem
        • IP clinics
      • EQE Candidates
        • Go back
        • Overview
        • Coffee-break questions
        • Daily D questions
        • European qualifying examination - Guide for preparation
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Overview
      • 50 Leading Tech Voices
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Governance
      • Go back
      • Overview
      • Communiqués
        • Go back
        • Overview
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • About eTendering
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • Invoicing
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • EPO Data Hub
      • Clarification on data sources
    • Social responsibility
      • Go back
      • Overview
      • Environment
      • Art collection
        • Go back
        • Overview
        • The collection
        • Let's talk about art
        • Artists
        • Media library
        • What's on
        • Publications
        • Contact
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Procedure
    • Annual reports
      • Go back
      • Overview
    • Organisation
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
        • Composition of the Presidium
          • Go back
          • Overview
          • Archive
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2023
      • Archive
    • Annual list of cases
    • Communications
    • Publications
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
    • Case Law from the Contracting States to the EPC
    • Oral proceedings
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Legal resources
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
      • Specific contact
      • Surveys
        • Go back
        • Overview
        • Search services
        • Examination services, final actions and publication
        • Opposition services
        • Patent filings
          • Go back
          • Overview
          • Detailed methodology
          • Archive
        • Online Services
        • Patent information
          • Go back
          • Overview
          • Innovation process survey
        • Customer services
        • Filing services
        • Website
        • Survey on electronic invoicing
        • Companies innovating in clean and sustainable technologies
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Forums
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2023 decisions
  • 2022 decisions
  • 2021 decisions
https://www.epo.org/en/node/w080013eu1
  1. Home
  2. W 0013/08 (Paramagnetic particles/PROMEGA) 23-09-2008
Facebook Twitter Linkedin Email

W 0013/08 (Paramagnetic particles/PROMEGA) 23-09-2008

European Case Law Identifier
ECLI:EP:BA:2008:W001308.20080923
Date of decision
23 September 2008
Case number
W 0013/08
Petition for review of
-
Application number
PCT/US1999/31207
IPC class
C12Q 1/68
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 35.91 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

Cell concentration and lysate clearance using paramagnetic particles

Applicant name
Promega Corporation
Opponent name
-
Board
3.3.08
Headnote
-
Relevant legal provisions
Patent Cooperation Treaty Art 34(3)(a)
Patent Cooperation Treaty R 13(1)
Patent Cooperation Treaty R 13(2)
European Patent Convention Art 154(3) 1973
Keywords

Unity of invention for groups of inventions 1 to 3 (no)

Unity of invention for groups of inventions 2 and 3 (yes)

Catchword
-
Cited decisions
G 0001/89
W 0006/90
Citing decisions
-

I. International patent application PCT/US99/31207 with the title "Cell concentration and lysate clearance using paramagnetic particles" was filed on 30 December 1999 with thirty-six claims. The application was published as WO 00/70040.

II. An International Search Report was established for the claims as filed and sent to the applicant on 29 September 2000. On 1 December 2000, the applicant filed under Article 19 PCT an amended set of claims (claims 1 to 28) which replaced the claims originally filed.

III. Independent claims 1, 8 and 21 of the amended set of claims read as follows:

"1. A method of using magnetic particles to concentrate or harvest cells, comprising the steps of:

(a) combining cells with magnetic particles, under conditions wherein the cells selectively adsorb directly to the particles thereby forming a complex, wherein said magnetic particles are selected from the group consisting of (1) pH dependent ion exchange particles and (2) silica magnetic particles consisting essentially of a magnetic core coated with a siliceous oxide having a hydrous siliceous oxide adsorptive surface; and

(b) isolating the complex from the solution by application of magnetic force.

8. A method of clearing a solution of disrupted biological material, according to steps comprising:

(a) providing a solution comprising a disrupted biological material;

(b) combining the solution with second magnetic particles under conditions wherein the disrupted biological material selectively adsorbs directly to the particles, thereby forming a complex, wherein said magnetic particles are selected from the group consisting of (1) pH dependent ion exchange particles and (2) silica magnetic particles consisting essentially of a magnitude core coated with a siliceous oxide having a hydrous siliceous oxide adsorptive surface; and

(c) separating the complex from the solution by application of magnetic force.

21. A method of isolating a target nucleic acid from a disrupted biological material, comprising the target nucleic acid, a first non-target material, and a second non-target material, comprising the steps of:

(a) combining a solution of the disrupted biological material with first magnetic particles under conditions wherein the first non-target material selectively adsorbs directly to the particles, thereby forming a first complex, wherein said magnetic particles are selected from the group consisting of (1) pH dependent ion exchange particles and (2) silica magnetic particles consisting essentially of a magnetic core coated with a siliceous oxide having a hydrous siliceous oxide adsorptive surface;

(b) separating the first complex from the solution of disrupted biological material by application of magnetic force, forming a cleared solution comprising the target nucleic acid and the second non-target material;

(c) combining the cleared solution with second magnetic particles under conditions wherein the target nucleic acid adsorbs to the second magnetic particles, forming a second complex;

(d) isolating the second complex from the cleared solution;

(e) washing the second complex by combining the second complex with a wash solution and separating the second complex from the wash solution by magnetic force; and

(f) combining the washed second complex with an elution solution, under conditions wherein the target material is desorbed from the second magnetic particles."

Dependent claims 2 to 7 and 9 to 20 concerned various embodiments of the methods claimed in, respectively, claim 1 and claim 8, on which they depended, directly or indirectly. Dependent claims 22 to 28 concerned different embodiments of the method of claim 21.

IV. On 2 April 2001 the European Patent Office, acting in its capacity as International Preliminary Examination Authority (IPEA), informed the applicant that the application was not considered to comply with the requirements of unity of invention (Rule 13.1, 13.2 and 13.3 PCT). Therefore, the IPEA held that there were three inventions claimed in the international application. In accordance with Article 34(3)(a) and Rule 68.2 PCT, the applicant was thus invited either to restrict the claims to one invention, or pay the examination fees for two additional inventions within a time limit of one month.

V. In the Invitation to Restrict or to Pay Additional Fees, the IPEA reasoned that "[t]he only common technical features which can be distinguished between the subject matter of claims 1, 8 and 21, are that said method claims refer to the use [of] magnetic particles to separate biological material present in a solution (e.g. cell, nucleic acid, etc) comprising the steps of: combining a solution containing said material with magnetic particles to form a complex, wherein said magnetic particles were selected from the group consisting of (1) pH dependent ion exchange particles and (2) silica magnetic particles consisting essentially of a magnetic core coated with siliceous oxide having a hydrous siliceous oxide adsorptive surface; and separating the complex from the solution by applying magnetic force."

VI. In the IPEA's view, these common technical features were known from documents:

(1): WO 98/31840, published on 23 July 1998;

(2): DE 43 07 262, published on 8 September 1994; and

(3): P.R. Levison et al., 1998, Journal of Chromatography A, Vol. 827, pages 337 to 334.

VII. The IPEA thus considered that, taking into account the state of the art, the subject-matter of claims 1, 8 and 21 was not linked by a common (new and inventive) special technical feature within the meaning of Rule 13.2 PCT. The claimed subject-matter was divided into the following three groups of inventions:

(i) Claims 1 to 7 directed to a method of using magnetic particles to concentrate or to harvest cells;

(ii) Claims 8 to 20 directed to a method of clearing a solution of disrupted biological material; and

(iii) Claims 21 to 28 directed to a method of isolating a target nucleic acid from a disrupted biological material.

VIII. On 30 April 2001, the applicant paid under protest two additional examination fees for the additional inventions (Rule 68.3(c) PCT). In its response to the IPEA's Invitation, dated 27 April 2001, the applicant maintained that unity of invention existed between all the claims of the application. In support of this view, it was submitted that:

- In each of the three groups of inventions indicated by the IPEA in the Invitation, either cells or disrupted biological material were combined with the same type of magnetic particles under conditions wherein the cells or the disrupted biological material adsorbed directly to the particles, thereby forming a complex. Thus, in accordance with Rule 13.2 PCT a link existed between the separate embodiments claimed in the independent and dependent claims of the application.

- In the method of using paramagnetic particles to concentrate or harvest cells according to claims 1 to 7 (first group of inventions), the cells to be concentrated or harvested selectively adsorbed directly to the particles thereby forming a complex.

- The method of claims 21 to 28 (third group of inventions) included an initial step of combining a solution of the disrupted biological material with first magnetic particles under conditions wherein the first non-target material selectively adsorbed to the particles, thereby forming a first complex.

- Claims 8 to 20 (second group of the inventions) included the same step, in which the disrupted biological material selectively adsorbed directly to the particles. In both groups of claims, the same types of magnetic particles were used to adsorb to the disrupted biological material.

- The method of isolating DNA described in document (1) did not include any step of adsorption of disrupted biological material other than the target DNA to silica magnetic particles. Therefore, it was clear that document (1) did not disclose this particular common element of the claims of groups 2 and 3 defined by the IPEA.

- Document (3) described various techniques for isolating nucleic acids using a specific type of magnetic bead with an anion exchanger, to which the nucleic acid of interest was adsorbed. However, at no point did document (3) teach or suggest the use of a magnetic particle with any type of ion exchanger to clear a solution of disrupted biological material or to isolate or harvest cells, a common element of all of the claims of the application.

- Since the applicant did not have sufficient time to obtain an English translation of document (2), its content could not be determined. Nevertheless, at least two of the three references cited in the IPEA's Invitation failed to teach or suggest the use of the types of magnetic particles used in the methods of the invention to clear a solution of disrupted biological material or to isolate or harvest cells.

IX. On 24 July 2001, the IPEA sent an Invitation to Pay a Protest Fee under Rule 68.3(e) PCT for the referral of the protest to a Board of Appeal. The invitation included the results of a review by a Review Panel of the justification for the Invitation to Restrict or to Pay Additional Fees of 2 April 2001. In the view of the Review Panel, the applicant had acknowledged that the use of magnetic particles as specified in claims 1, 8 and 21 to separate biological material present in a solution (eg. cell, nucleic acid, etc) was a technical feature common to the three groups of inventions defined in the Invitation of 2 April 2001. With regard to the applicant's arguments in respect of document (1), the Review Panel considered that the applicant had implicitly acknowledged that the target DNA isolated according to the method of document (1) did indeed represent biological material. This also applied to document (3), since the sole difference between the teachings of documents (1) and (3) was that in the latter pH dependent ion exchange particles were used. Document (2), which was acknowledged in the application as filed to be a particularly relevant prior art document, disclosed the separation of biological material as well. Thus, the link between the three groups of inventions was known from prior art documents D1 to D3 and, therefore, no common inventive concept linked the three groups of inventions.

X. On 20 August 2001, the protest fee was paid. The applicant did not submit any further arguments in response to the findings of the Review Panel.

1. The international application under consideration has an international filing date of 30 December 1999. Pursuant to Article 1(6) of the Decision of the Administrative Council of 28 June 2001 on the transitional provisions under Article 7 of the Act revising the European Patent Convention of 29 November 2000, Articles 154(3) and 155(3) EPC 1973 shall continue to apply to PCT application pending at the time of entry into force of the EPC 2000. Details of the procedure are guided by the Decision of the President of the EPO dated 24 June 2007, Article 3 (Special edition No. 3 OJ EPO, 140), and the Notice of the EPO dated June 2007, points 6 to 9 (Special edition No. 3 OJ EPO, 142). Accordingly, the Boards of Appeal shall continue to be responsible for deciding on protests made against the charging of an additional fee under Article 17, paragraph 3(a) or Article 34, paragraph 3(a) PCT, in their capacity as a review body specified in Rule 40.2(c) PCT, second sentence.

2. The payment was made in time, and the protest is thus considered to have been made (Rule 40.2(e) PCT, second sentence). The protest is reasoned, pursuant to the requirements of Rule 40.2(c) PCT, first sentence and is therefore admissible.

Examination of the protest

3. According to Rule 13.1 PCT, an international patent application shall relate to one invention only or to a group of inventions so linked as to form a single inventive concept. If the International Preliminary Examining Authority (IPEA) considers that the international application does not comply with the requirements of unity of invention, it may invite the applicant, at his option, to restrict the claims so as to comply with the requirements or to pay additional fees (see Article 34.3(a) PCT).

4. In the present case, the Invitation to Restrict or to Pay Additional Fees issued by the IPEA on 2 April 2001 (in the following "the Invitation") established that the requirement of unity of claims was not fulfilled because the single concept linking the three groups of inventions claimed was neither novel nor inventive in view of documents D1, D2 or D3. The IPEA defined the linking concept as the use of magnetic particles selected from the group consisting of (1) pH dependent ion exchange particles and (2) silica magnetic particles consisting essentially of a magnetic core coated with siliceous oxide having a hydrous siliceous oxide adsorptive surface, in a method to separate biological material present in a solution, the method comprising the steps of: combining a solution containing said material with magnetic particles to form a complex; and separating the complex from the solution by application of magnetic force.

5. In the IPEA's formulation of the general concept shared by the claimed inventions, the feature "biological material" - which does not appear as such in the claims - defines broadly the material that binds to the magnetic particles to form the complex, ie. cells (see method of claims 1 to 7), disrupted biological material (see method of claims 8 to 20) or nucleic acid (see method of claims 21 to 28). "Biological material" has, thus, the same meaning as the term "solute" used in the passage of the application starting on page 9, line 3 and ending on page 11, line 8. In this passage, "solute" is defined as "... the type of material to be isolated from or removed from a solution using magnetic particles, according to a method of the present invention." (see page 9, lines 11 and 12). According to the application, the "solute" can be intact cells (see page 9, lines 12 and 13; and page 10, lines 10 and 11), disrupted biological material (see page 9, lines 14 and 15; and page 10, lines 12 to 21) or a target nucleic acid (see page 15, lines 15 to 17; and paragraph bridging pages 10 and 11). Hence, the concept linking the three groups of inventions formulated by the IPEA in the Invitation is in full agreement with the teaching of the application.

6. This linking concept was, however, considered to be known in the state of the art, as represented in particular by documents (1) to (3).

7. Document (1) describes methods of isolating biological target materials using silica magnetic particles, by combining the silica magnetic particles and a solution including the biological target material to form a complex (see page 7, lines 12 to 21). The biological material to be isolated is preferably a nucleic acid or a protein; however, also other biological materials can be isolated (see page 12, lines 2 to 18; and page 15). It is stated on page 10, lines 3 to 9 of document (1) that the most preferred form of silica magnetic particle is a "siliceous-oxide coated magnetic particle" or "SOCM particle" which is comprised of siliceous oxide coating a core of at least one particle of superparamagnetic or paramagnetic material. The SOCM particle used in the methods described in document (1) also has an adsorptive surface of hydrous siliceous oxide, a surface characterized by having silanol groups thereon (see page 10, lines 7 to 9).

8. Thus, having regard to the content of document (1), the concept linking the three groups of inventions defined in the Invitation, in particular the use of silica magnetic particles consisting essentially of a magnetic core coated with siliceous oxide having a hydrous siliceous oxide adsorptive surface in a method aimed at separating certain biological material from further material present in the solution, is not new.

9. Nor is the concept of using pH dependent ion exchange magnetic particles, as document (3) describes the use of DEAE-Magarose, an ion exchange agarose bead containing a paramagnetic component, in a method of separating plasmid DNA from further biological material present in a bacterial cell lysate, or genomic DNA from bacterial cells and blood (see page 338, left column, second full paragraph, lines 11ff.)

10. The board thus concludes that, since the general concept shared by the three groups of inventions to which the claims relate, as defined in the IPEA's Invitation (see point 4 above) lacks novelty, the claims are not linked by a "special technical feature" within the meaning of Rule 13.2 PCT. Thus, the finding of the IPEA that the application including claims 1 to 28 filed on 1 December 2000 does not fulfil the requirement of unity of invention was justified.

11. The board has considered the arguments in support of unity of invention put forward by the applicant in its response dated 27 April 2001. In particular, the applicant argued that neither document (1) nor document (3) teaches or suggests a common element of all the claims of the application, namely the use of magnetic particles to clear a solution of biologically disrupted material or to isolate or harvest cells.

12. This argument cannot be accepted. As stated above, both types of magnetic particles specified in the claims were part of the state of the art at the priority date (see documents (1) and (3)). Moreover, it was known that such magnetic particles could be used in a method of separating the biological target material from further material present in the solution, by selectively adsorbing the biological target material (eg. plasmid or genomic DNA) to the surface of the particles, to form a complex which is subsequently isolated by applying magnetic force (see documents (1) and (3)).

13. Having regard to the state of the art as apparent from documents (1) and (3), the problem to be solved by the method of claims 1 to 7 (first group of inventions) can be formulated as applying the method described in these documents to the isolation of a different biological target material, and the proposed solution consists in the use of magnetic particles as specified in claim 1 to concentrate or harvest cells.

14. As concerns claims 8 to 20, the technical problem to be solved may be formulated as providing a method of enriching the desired biological target material in the solution. The solution proposed in claims 8 to 20 consists in adsorbing further biological material present in the solution (so-called "disrupted biological material") to the surface of the magnetic particles, and separating the complex formed, so that the biological target material remains in the solution. This is apparent from the passage on page 10, lines 17 to 21 of the application.

15. It follows from the above that the methods corresponding to the first and second group of inventions as defined in the Invitation differ not only in the technical problem solved, but also in the relevant effect achieved. Thus, a single general concept within the meaning of Rule 13.1 PCT linking the first and the second group of inventions cannot be acknowledged (see W 6/90; OJ EPO 1991, 438).

16. In its response to the Invitation, the applicant argued further that the method claimed in claim 8 for clearing a solution of disrupted biological material represented the first step of the method of isolating a target nucleic acid from a disrupted biological material as claimed in claim 21. Thus, the second and the third group of inventions shared a common element which was described neither in document (1) nor in document (3).

17. This argument, which was apparently not considered by the Review Panel when reviewing the Invitation, merits closer examination. The Board notes that the method of isolating a target nucleic acid from a disrupted biological material of claim 21 comprises two steps in which magnetic particles are used, the first step (see step (a)) consisting essentially in clearing a solution of disrupted biological material by a method as defined in claim 8.

18. The use of the magnetic particles specified in claims 8 and 21 for clearing a solution of disrupted biological material may, thus, be considered to be the general concept linking the inventions claimed in claims 8 to 20 (second group of inventions) and claims 21 to 28 (third group of inventions). Hence, the sole remaining question is whether or not this concept can be viewed as an inventive link between the two groups, in view of documents (1) to (3) cited in the Invitation.

19. None of the prior art documents (1) to (3) appears to describe or even suggest removing undesired biological material from a solution by first selectively adsorbing the material to the surface of magnetic particles to form a complex, and then separating the complex by applying magnetic force. Rather, documents (1) to (3) describe only methods in which the biological target material is adsorbed to the particles to form a complex which is subsequently isolated from the solution.

20. The use of the magnetic particles specified in the claims for clearing a solution of disrupted biological material may, thus, be considered as a special technical feature within the meaning of Rule 13.2 PCT, which defines the contribution made by the methods of claims 8 to 28 over the prior art. Hence, a single general inventive concept linking the second and the third group of inventions defined in the Invitation and, consequently, unity of invention within the meaning of Rule 13.1 PCT for the inventions in claims 8 to 28 is acknowledged.

21. The Board wishes to note that, as stated in decision G 1/89 of the Enlarged Board of Appeal (OJ EPO 1991, 155; see point 8.1 of the Reasons), the consideration of the prior art made in the framework of assessing unity of invention under Rule 13.1 PCT represents only a provisional opinion on novelty and inventive step which is in no way binding upon the national or regional authorities subsequently responsible for the further examination of the application.

22. Summarizing the above, the Board concludes that, contrary to the view expressed by the IPEA in the Invitation and confirmed by the Review Panel, the application relates to only two groups of inventions which are not so linked as to form a single general inventive concept, the first group of inventions corresponding to claims 1 to 7 (first group as defined in the Invitation), and the second group to claims 8 to 28 (second and third group as defined in the Invitation). Thus, the Invitation to pay additional fees is justified only for one additional examination fee.

Refund of the protest fee

23. The protest, as explained above, is partially justified. Pursuant to Rule 40.2(e) PCT, last sentence, the applicant is not entitled to the reimbursement of the protest fee, as the protest was not entirely justified.

Order

ORDER

For these reasons it is decided that:

Refund of one examination fee paid by the applicant is ordered.

Footer - Service & support
  • Service & support
    • FAQ
    • Contact us
    • Subscription centre
    • Official holidays
    • Publications
    • Procedural communications
    • Ordering
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
SoMe facebook 0
European Patent Office
EPO Jobs
SoMe instagram
EuropeanPatentOffice
SoMe linkedIn
European Patent Office
EPO Jobs
EPO Procurement
SoMe twitter
EPOorg
EPOjobs
SoMe youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility